JENNIFER SPORS: Open Payments
NPI 1003487604 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$629 in 23 payments from 13 companies in 2025. Trend: 2023 $247 · 2024 $693 · 2025 $629
Food & beverage: $629
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 7 | $219 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $116 |
| AstraZeneca Pharmaceuticals LP | 2 | $43 |
| BridgeBio Pharma, Inc. | 2 | $39 |
| PFIZER INC. | 2 | $36 |
| Actelion Pharmaceuticals US, Inc. | 2 | $28 |
| Novartis Pharmaceuticals Corporation | 1 | $28 |
| ABIOMED | 1 | $28 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| Alnylam Pharmaceuticals Inc. | 1 | $21 |
Products named: THORATEC HEARTMATE 3 LVAS IMPLANT KIT, JARDIANCE, FARXIGA, CARDIOMEMS, Attruby, OPSUMIT, LEQVIO, EVKEEZA.
Industry payments across IN — which companies pay providers there.
